(© Medical Pharma Resource GmbH – Using Pictures ©: https://de.123rf.com/profile_istanbul2009; https://de.123rf.com/profile_feellgood/)
Langenfeld, 12/15/2021

Medical Pharma Resource GmbH (Medical Pharma) based in Langenfeld (Rhld.) is starting to distribute a new medical cannabis product from Canada on the German market. With a view to providing this high-quality medicine to patients throughout Germany via pharmacies, Medical Pharma has signed an exclusive partnership with Beacon Medical Germany.

Medical Pharma promotes high quality cannabis products-based treatment methods that target unmet medical needs of patients. The company sees great potential in the treatment of various disease symptoms through numerous international research results on phytocannabinoids.

Since the company was founded, national and international collaborations have been established in this regard with partners in the areas of analytical testing, narcotics manufacturing, narcotics storage, cannabis producers and logistics. Medical Pharma is still in international negotiations with various producers from different countries to import, manufacture and distribute products under the brand name “MPRCanna®” and partner products.

In line with this, the company prepared internally for the granting of the manufacturing license according to § 13 AMG and for the import license according to § 72 AMG. The preparations were completed at the end of October 2021. The company is currently awaiting written confirmation of the date for the inspection by the authorities. By the end of February 2022, Medical Pharma is expected to have all licenses to import its own products and those of its partners.

The exclusive partner, Beacon Medical Germany GmbH, is a German subsidiary of Canada-based VIVO Cannabis Inc.

The exchange listed VIVO Cannabis Inc. is a Canadian company that is active in the cultivation, production and marketing of cannabis products. Its subsidiary ABcann Medicinals owns a medical cannabis flower production facility in Napanee – Ontario, Canada. In March ABcann Medicinals’ Vanluven facility has received EU-GMP certification in accordance with GMP Vol. 4 – Part 1, by the Brandenburg Health Authority, the State Office for Occupational Safety, Consumer Protection and Health (“LAVG “). The certification allows VIVO, through ABcann Medicinals, to export products for sale in European and other markets for which products must be manufactured according to strict GMP standards.

At the same time, Beacon Medical Germany GmbH received an import license from the authority to import Napanee medical cannabis flowers into Germany and the EU.

The exclusive partnership with VIVO’s German subsidiary, Beacon Medical Germany GmbH, is a great strategic success for both partners. Our many years of experience will ensure that new quality standards in therapy with medical cannabis are set for patients in Germany. Through its Harvest Medicine subsidiary, a patient-centered network of medical cannabis clinics owned by VIVO over 150,000 patient visits have been managed, explains Engin Ates, CEO and Co-Founder of Medical Pharma Resource GmbH, who has also been successfully participating in cannabis therapy as a pain patient himself for years.

Public Relations Medical Pharma Resource

Dr. Daniel König
+49 (0) 2173 940 95 91

About Medical Pharma Resource ®

Medical Pharma Resource (Medical Pharma) GmbH was founded at the end of 2018 and is based in Langenfeld, Germany. The focus of this pharmaceutical company is the import and distribution of prescription medical cannabis products and applicators.
Medical Pharma is a licensed pharmaceutical wholesaler according to § 52a of the German Medicines Act (AMG) and has the permission to handle narcotics according to § 3 of the German Narcotics Act (BtMG).
Further, the internal preparations are completed for the granting of the manufacturing license according to § 13 AMG and the import license according to § 72 AMG. Medical Pharma expects to receive all licenses by the end of February 2022.

The philosophy of Medical Pharma

The core of Medical Pharma philosophy is to provide patients with new high quality medicinal cannabis flowers.
Medical Pharma Resource GmbH has taken the goal to consider the criteria that are important for the well-being of patients when selecting manufacturers in order to ensure the highest level of quality, efficacy, transparency and availability.
The partner products, the own products and also selectively products of the German competitors can be offered via Medical Pharma’s own sales platform.
For more information, please visit: Medical Pharma Resource

About VIVO Cannabis ™

VIVO Cannabis is recognized for trusted, premium cannabis products and services in Canada It holds cultivation, processing and sales licenses from Health Canada and operates world-class state of the art indoor and seasonal cultivation facilities. VIVO has a collection of premium brands in Canada, each targeting different customer segments, including Canna Farms ™, Beacon Medical ™, Fireside ™, Fireside-X ™ and Lumina ™. Harvest Medicine ™, VIVO’s client-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.
For more information, visit: VIVO Cannabis Inc. and Beacon Medical Germany

Business partner

We invite you to join us as a partner with your resources and participate proactively in the supply chain of the German & EU medical cannabis market. A good medical alternative with fewer risks and side effects.
As a partner we can guarantee you security, continuity, transparency and trust.
Internal forwarding: Click on “CONTINUE” please